1 School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China;2 Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangzhou, Guangdong 510006, China 在期刊界中查找 在百度中查找 在本站中查找
1 School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China;2 Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangzhou, Guangdong 510006, China 在期刊界中查找 在百度中查找 在本站中查找
1 School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China;2 Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangzhou, Guangdong 510006, China 在期刊界中查找 在百度中查找 在本站中查找
1 School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China;2 Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangzhou, Guangdong 510006, China 在期刊界中查找 在百度中查找 在本站中查找
With the growing concern about the role of intestinal microbes in human health and disease, the metabolism of intestinal microorganisms has become one of the research hotspots in recent years. Previous studies have shown that applying intestinal microbiome and metabolomics may have important value in the host physiology, disease pathology, and pharmaceutical pharmacology. This paper reviews the research progress on the combined application of intestinal microbial genomics and metabolomics analysis.